| Titre : | Medications for opioid use disorder. For healthcare and addiction professionals, policymakers, patients, and families |
| Abroge : | |
| Auteurs : | SAMHSA |
| Type de document : | Rapport |
| Mention d'édition : | Publication No. PEP20-02-01-006 |
| Editeur : | Rockville, MD : SAMHSA, 2020 |
| Collection : | Treatment Improvement Protocol (TIP), num. 63 |
| Format : | 332 p. |
| Langues: | Anglais |
| Discipline : | TRA (Traitement et prise en charge / Treatment and care) |
| Mots-clés : |
Thésaurus TOXIBASE DONNEE PROBANTE ; TRAITEMENT ; PHARMACOTHERAPIE ; TRAITEMENT DE MAINTENANCE ; PHARMACOLOGIE ; METHODE ; ORIENTATION ; DEPISTAGE ; OPIOIDES ; HEROINE ; FENTANYL ; MEDECIN GENERALISTE ; PERSONNEL MEDICAL ; BUPRENORPHINE ; METHADONE ; NALTREXONEThésaurus Géographique ETATS-UNIS |
| Résumé : | The goal of treatment for opioid addiction or opioid use disorder (OUD) is remission of the disorder leading to lasting recovery. Recovery is a process of change through which individuals improve their health and wellness, live self-directed lives, and strive to reach their full potential. This Treatment Improvement Protocol (TIP) reviews the use of the three Food and Drug Administration (FDA)-approved medications used to treat OUD - methadone, naltrexone, and buprenorphine - and the other strategies and services needed to support recovery for people with OUD. |
| Domaine : | Autres substances / Other substances ; Drogues illicites / Illicit drugs |
| Affiliation : | USA |
| URL : | Executive summary (16 p.) |
| Lien : | https://store.samhsa.gov/product/TIP-63-Medications-for-Opioid-Use-Disorder-Full-Document/PEP20-02-01-006 |
Exemplaires
| Disponibilité |
|---|
| aucun exemplaire |
Accueil
